mitomycin has been researched along with transforming growth factor beta in 22 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 5 (22.73) | 18.2507 |
| 2000's | 7 (31.82) | 29.6817 |
| 2010's | 9 (40.91) | 24.3611 |
| 2020's | 1 (4.55) | 2.80 |
| Authors | Studies |
|---|---|
| Basson, MD; Flynn, SD; Jena, BP; Madri, JA; Modlin, IM | 1 |
| Dignass, AU; Podolsky, DK | 1 |
| Horita, S; Kawashima, A; Murai, K; Nihei, H; Nitta, K; Ozu, H; Tsutsui, T; Uchida, K; Yumura, W | 1 |
| Kale, VP; Limaye, LS | 1 |
| Alexander, RA; Cordeiro, MF; D'Esposita, F; Gay, JA; Khaw, PT; Reichel, MB | 1 |
| Caspary, WF; Milovic, V; Murphy, GM; Stein, J; Teller, IC | 1 |
| Cordeiro, MF | 1 |
| Abe, M; Endo, Y; Gotoh, M; Gunji, T; Hojo, H; Ise, K; Kanazawa, Y; Matsuyama, S; Sato, Y | 1 |
| Gotoh, M; Gunji, T; Ise, K; Ishii, S; Kanazawa, Y; Matsuyama, S; Sato, Y; Yamashita, M | 1 |
| Chen, T; Koch, RJ; Kunnavatana, SS | 1 |
| Cho, YJ; Choi, SI; Kim, EK; Kim, TI; Lee, HK | 1 |
| Nelson, LD; Sharpe, DT; Stevenson, S; Thornton, MJ | 1 |
| Choi, SI; Chung, WS; Han, KE; Kim, BY; Kim, EK; Kim, TI | 1 |
| Arslan, S; Aydemir, O; Dağlı, AF; Güler, M | 1 |
| Brown, DJ; Jester, JV; Nien, CJ; Vasiliou, V | 1 |
| Akın, MM; Demir, T; Eren, K; Kobat, S; Turgut, B | 1 |
| Akin, MM; Demir, T; Eren, K; Turgut, B | 1 |
| Chong, RS; Chu, SWL; Lee, YS; Toh, LZ; Wong, TTL | 1 |
| Burián, K; Endrész, V; Igaz, N; Jenovai, K; Kiricsi, M; Kovács, D; Molnár, J; Rovó, L; Spengler, G; Szabó, D; Tiszlavicz, L | 1 |
| Hajam, IA; Kim, J; Lee, JH | 1 |
| Jang, SW; Jeong, H; Kim, JY; Lee, CM; Lee, H; Lee, JH; Park, SY; Shin, JA; Tchah, H | 1 |
| Chong, YY; Ding, M; Fang, XJ; Gu, WY; Li, N; Li, Y; Tong, P; Xu, DD | 1 |
2 review(s) available for mitomycin and transforming growth factor beta
| Article | Year |
|---|---|
Beyond Mitomycin: TGF-beta and wound healing.
Topics: Antibiotics, Antineoplastic; Filtering Surgery; Humans; Mitomycin; Signal Transduction; Transforming Growth Factor beta; Wound Healing | 2002 |
Clinical findings and treatments of granular corneal dystrophy type 2 (avellino corneal dystrophy): a review of the literature.
Topics: Chromosomes, Human, Pair 5; Contraindications; Cornea; Corneal Dystrophies, Hereditary; Corneal Transplantation; Extracellular Matrix Proteins; Humans; Keratomileusis, Laser In Situ; Lens Implantation, Intraocular; Mitomycin; Mutation; Phacoemulsification; Photorefractive Keratectomy; Postoperative Complications; Recurrence; Refractive Surgical Procedures; Transforming Growth Factor beta | 2010 |
20 other study(ies) available for mitomycin and transforming growth factor beta
| Article | Year |
|---|---|
Independent modulation of enterocyte migration and proliferation by growth factors, matrix proteins, and pharmacologic agents in an in vitro model of mucosal healing.
Topics: Cell Division; Cell Line; Cell Movement; Epidermal Growth Factor; Extracellular Matrix Proteins; Genistein; Growth Substances; Humans; Intestinal Mucosa; Isoflavones; Lasers; Mitomycin; Transforming Growth Factor beta; Tyrosine 3-Monooxygenase; Wound Healing | 1992 |
Cytokine modulation of intestinal epithelial cell restitution: central role of transforming growth factor beta.
Topics: Animals; Cell Division; Cell Line; Cell Movement; Cytokines; Dose-Response Relationship, Drug; Epithelial Cells; Epithelium; Intestines; Mitomycin; Rats; RNA, Messenger; Transforming Growth Factor beta | 1993 |
[Role of glomerular mesangial cells in the regulation of glomerular endothelial cell growth].
Topics: Animals; Cattle; Cell Division; Cells, Cultured; Culture Media, Conditioned; Endothelium; Glomerular Mesangium; Mitomycin; Transforming Growth Factor beta | 1993 |
Stimulation of adult human bone marrow by factors secreted by fetal liver hematopoietic cells: in vitro evaluation using semisolid clonal assay system.
Topics: Adult; Bone Marrow Cells; Cell Count; Cell Line; Cell Survival; Colony-Forming Units Assay; Dose-Response Relationship, Drug; Enzyme-Linked Immunosorbent Assay; Erythropoietin; Fetus; Granulocyte-Macrophage Colony-Stimulating Factor; Hematopoietic Stem Cells; Humans; Interleukin-3; Liver; Mitomycin; Transforming Growth Factor beta | 1999 |
Transforming growth factor-beta1, -beta2, and -beta3 in vivo: effects on normal and mitomycin C-modulated conjunctival scarring.
Topics: Animals; Cicatrix; Collagen; Conjunctiva; Conjunctival Diseases; Elastic Tissue; Fluorescent Antibody Technique, Indirect; Mice; Mice, Inbred BALB C; Mitomycin; Prospective Studies; Random Allocation; Recombinant Proteins; Transforming Growth Factor beta | 1999 |
Deoxycholic acid stimulates migration in colon cancer cells.
Topics: Caco-2 Cells; Cell Division; Cell Movement; Colonic Neoplasms; Deoxycholic Acid; Dose-Response Relationship, Drug; Humans; Mitomycin; Protein Kinase C; Transforming Growth Factor beta; Tumor Cells, Cultured | 2001 |
Survival of mitomycin C-treated pancreatic islet xenografts is mediated by increased expression of transforming growth factor-beta.
Topics: Animals; Antibiotics, Antineoplastic; Graft Survival; Islets of Langerhans Transplantation; Male; Mice; Mice, Inbred C57BL; Mitomycin; Rats; Rats, Inbred Strains; Time Factors; Transforming Growth Factor beta; Transplantation, Heterologous | 2004 |
Transforming growth factor-beta signaling is enhanced following mitomycin-C treatment of islet xenograft.
Topics: Animals; Cytokines; Gene Expression Regulation; Graft Survival; Islets of Langerhans; Islets of Langerhans Transplantation; Mice; Mitomycin; Rats; RNA, Messenger; Signal Transduction; Subrenal Capsule Assay; Th1 Cells; Th2 Cells; Transforming Growth Factor beta; Transplantation, Heterologous | 2004 |
Effects of mitomycin-C on normal dermal fibroblasts.
Topics: Adult; Antibiotics, Antineoplastic; Apoptosis; Cell Line; Cell Proliferation; Culture Media, Serum-Free; Dermis; Enzyme-Linked Immunosorbent Assay; Fibroblast Growth Factor 2; Fibroblasts; Humans; In Vitro Techniques; Mitomycin; Transforming Growth Factor beta; Transforming Growth Factor beta1 | 2006 |
Mitomycin C induces apoptosis in cultured corneal fibroblasts derived from type II granular corneal dystrophy corneas.
Topics: Apoptosis; bcl-2-Associated X Protein; Cell Survival; Cells, Cultured; Cornea; Corneal Dystrophies, Hereditary; Dose-Response Relationship, Drug; Extracellular Matrix Proteins; Fibroblasts; Gene Expression Regulation; Humans; Mitomycin; RNA, Messenger; Time Factors; Transforming Growth Factor beta | 2008 |
17beta-estradiol regulates the secretion of TGF-beta by cultured human dermal fibroblasts.
Topics: Biocompatible Materials; Cell Movement; Cell Proliferation; Cells, Cultured; Collagen; Dermis; Estradiol; Estrogens; Fibroblasts; Humans; Mitomycin; Skin; Transforming Growth Factor beta; Transforming Growth Factor beta1; Wound Healing | 2008 |
Modulation of postoperative scarring with tacrolimus and octreotide in experimental glaucoma filtration surgery.
Topics: Administration, Topical; Alkylating Agents; Animals; Cicatrix; Conjunctival Diseases; Disease Models, Animal; Fibroblast Growth Factor 2; Fibroblasts; Fibrosis; Filtering Surgery; Glaucoma; Immunoenzyme Techniques; Immunosuppressive Agents; Leukocyte Count; Mitomycin; Octreotide; Ophthalmic Solutions; Postoperative Complications; Rabbits; Tacrolimus; Transforming Growth Factor beta | 2012 |
Quiescent keratocytes fail to repair MMC induced DNA damage leading to the long-term inhibition of myofibroblast differentiation and wound healing.
Topics: Actins; Animals; Cell Differentiation; Cell Proliferation; Cells, Cultured; Chemokine CCL2; Cicatrix; Comet Assay; Cornea; Corneal Injuries; Corneal Keratocytes; Culture Media, Serum-Free; DNA Damage; DNA Repair; Histones; Mitomycin; Myofibroblasts; Rabbits; Transcription, Genetic; Transforming Growth Factor beta; Wound Healing | 2012 |
Topical infliximab for the suppression of wound healing following experimental glaucoma filtration surgery.
Topics: Animals; Antibodies, Monoclonal; Fibroblast Growth Factors; Filtering Surgery; Glaucoma; Infliximab; Male; Mitomycin; Platelet-Derived Growth Factor; Rabbits; Trabeculectomy; Transforming Growth Factor beta; Wound Healing | 2014 |
The Suppression of Wound Healing Response with Sirolimus and Sunitinib Following Experimental Trabeculectomy in a Rabbit Model.
Topics: Alkylating Agents; Angiogenesis Inhibitors; Animals; Disease Models, Animal; Fibroblast Growth Factor 2; Fibroblast Growth Factors; Immunosuppressive Agents; Indoles; Male; Mitomycin; Platelet-Derived Growth Factor; Pyrroles; Rabbits; Sirolimus; Sunitinib; Trabecular Meshwork; Trabeculectomy; Transforming Growth Factor beta; Wound Healing | 2016 |
Inhibition of Monocyte Chemoattractant Protein 1 Prevents Conjunctival Fibrosis in an Experimental Model of Glaucoma Filtration Surgery.
Topics: Animals; Antifibrinolytic Agents; Cell Survival; Chemokine CCL2; Collagen; Conjunctiva; Disease Models, Animal; Enzyme Inhibitors; Fibroblasts; Fibronectins; Fibrosis; Filtering Surgery; Glaucoma; Glaucoma Drainage Implants; Mice; Mice, Inbred C57BL; Mitomycin; Osteonectin; Receptors, CCR2; Transforming Growth Factor beta | 2017 |
Antifibrotic effect of mitomycin-C on human vocal cord fibroblasts.
Topics: Actins; Cell Culture Techniques; Cell Line; Fibroblasts; Fibrosis; Humans; Laryngectomy; Mitomycin; Transforming Growth Factor beta; Vocal Cords; Wound Healing | 2019 |
Human antigen presenting cells stimulated with Salmonella delivered influenza antigens induce cytokine production and proliferation of human CD4
Topics: Animals; Antigen Presentation; Antigen-Presenting Cells; Antigens, Viral; CD4-Positive T-Lymphocytes; Cell Proliferation; Coculture Techniques; Hemagglutinin Glycoproteins, Influenza Virus; Humans; Immunity, Cellular; Influenza A Virus, H7N9 Subtype; Influenza, Human; Interferon-gamma; Interleukins; Mitomycin; Neuraminidase; Primary Cell Culture; Recombinant Proteins; Salmonella typhimurium; Transforming Growth Factor beta; Viral Matrix Proteins | 2019 |
Antifibrotic Effects of Sakuraso-Saponin in Primary Cultured Pterygium Fibroblasts in Comparison With Mitomycin C.
Topics: Actins; Alkylating Agents; Blotting, Western; Cell Movement; Cell Survival; Cells, Cultured; Fibroblasts; Fibrosis; Humans; Mitomycin; Phosphorylation; Pterygium; Saponins; Smad2 Protein; Smad4 Protein; Tenon Capsule; Transforming Growth Factor beta | 2019 |
Synergistic effects of low‑dose chemotherapy and T cells in renal cell carcinoma.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Renal Cell; Cell Line, Tumor; Chemotaxis, Leukocyte; Cisplatin; Combined Modality Therapy; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; Female; Humans; Immunotherapy, Adoptive; Kidney Neoplasms; Mice; Mitomycin; Primary Cell Culture; Signal Transduction; T-Lymphocytes, Cytotoxic; Transforming Growth Factor beta | 2020 |